The present disclosure generally relates to an authentication system for authenticating medical solution containers. More particularly, the present disclosure relates to an authentication system of solution containers used in apheresis or blood processing procedures.
Infusion solutions, blood additive solutions, blood component solutions, replacement fluids, and other medical solutions used in apheresis or blood processing procedures are contained in solution containers having closed-off access ports that maximize solution sterility until the container is opened at the time of use. Access ports of different solution containers and different manufacturers come in a variety of types that are accessed through corresponding access tools operated by a human operator. The various types of ports include membrane ports, which are ports that are sealed off by a membrane and punctured by a piercing tool such as a cannula or spike; luer-fitted ports, which are ports fitted with a female luer fitting and breached by a tool with a complementary male fitting; and other fitted ports, which are accessed by corresponding tools that mate with the structure of the port. Generally, an access tool is often part of a set or kit manufactured for a specific type of apheresis or blood processing procedure and is connected by tubing to an intended destination of the solution within the kit.
In some cases, two or more medical solution containers may be used simultaneously during apheresis or blood processing procedures. For example, various combinations of saline solution bags, anti-coagulant bags, RBC additive bags, platelet additive bags, and/or a variety of replacement fluids, such as albumin, RBCs, platelets, etc. may be used in a single apheresis or blood processing procedure. Although these solutions have very different functions and properties, the containers in which they are held are often quite similar in appearance, and it is up to the human operator to make sure that the correct access tool accesses the correct solution container.
One embodiment relates to a blood processing system, comprising a blood processing device having a user interface and a memory. The system also comprises a database of medical solutions identifiable by identifiers and a fluid circuit for use with the blood processing device having an inlet for a medical solution. The blood processing device is configured to guide a user through one or more steps of a blood processing procedure including prompting a user to input an identifier of a medical solution, compare the identifier to information within the database, and authorize use of the medical solution upon verification of the identifier within the database.
Another embodiment relates to a blood processing system, comprising a blood processing device having a user interface and a memory, a database of medical solutions identifiable by identifiers, and a processing circuit. The processing circuit is configured to guide a user through one or more steps of a blood processing procedure including prompting the user via the user interface to execute one or more actions as part of a step, prompt the user via the user interface to input an identifier of a medical solution, receive the identifier of the medical solution via the user interface and identify the medical solution within the database based on the received identifier, and in response to identifying the medical solution within the database, proceeding with a step of the blood processing procedure.
Another embodiment relates to a blood processing system, comprising a blood processing device having a user interface and a memory, a database of medical solutions identifiable by identifiers, a medical solution port, and a processing circuit. The processing circuit is configured to provide a prompt to a user via the user interface as part of a multi-step blood processing procedure operated by the blood processing system. The processing circuit is also configured to receive an identifier of a medical solution from a user via the user interface before a step in the procedure, to determine whether the identifier is approved in the database for the step, and, based on the determination, to enable the blood processing system to perform the step of the procedure to process the medical solution via the medical solution port.
Features, aspects, and advantages of the present embodiments will become apparent from the following description, appended claims, and the accompanying exemplary embodiments shown in the drawings, which are briefly described below.
There are several aspects of the present subject matter which may be embodied separately or together in the devices and systems described and claimed below. These aspects may be employed alone or in combination with other aspects of the subject matter described herein, and the description of these aspects together is not intended to preclude the use of these aspects separately or the claiming of such aspects separately or in different combinations as set forth in the claims appended hereto.
In some embodiments, solutions and kits of which the access tools are a part may not need to be procured from the same manufacturer.
In some embodiments, cross-access or improper intermixing or substitution of critically distinct fluids can be prevented.
In some embodiments, a practicable and low-cost manner for operators working with products from different manufacturers can be provided.
Some embodiments may allow for a standardized fail safe that could be implemented across multiple product lines and manufacturers.
While described with reference to an apheresis system, the subject matter presented herein may be applied to other blood processing systems (e.g., dialysis machines, etc.) or other medical systems (e.g., internal or external infusion pumps, enteral feeding pumps, etc.). In some embodiments, the teachings herein could be used on any medical system that involves connecting a specific medical solution at a particular time or step within a multi-step procedure.
Referring to
Referring to
In one embodiment, the flow circuit 12 may be a “two needle” system, which includes a pair of blood source access devices 14 and 14a (e. g., phlebotomy needles) for fluidly connecting a blood source with the flow circuit 12. The blood source access devices 14 and 14a may be connected by tubing to a left cassette 16. One of the blood source access devices 14 may be used to draw blood from the blood source into the flow circuit 12 and is connected to the left cassette 16 by a y-connector 18. The other leg of the y-connector 18 is connected to tubing 31 which leads to a middle cassette 16a. The tubing 31 is connected, through the middle cassette 16a, to additional tubing 30c, which includes a container access tool 40c (e.g., a sharpened cannula or spike connector) for accessing the interior of a container 20c. During a blood processing procedure, a medical solution from the container 20c may be added to the blood from the blood source at the y-connector 18 prior to entering the left cassette 16.
The other blood source access device 14a may be used to deliver or return blood, a blood component, and/or some other medical solution to the blood source and is also connected to the left cassette 16 by a y-connector 29. The other leg of the y-connector 29 is connected to tubing 28 connected at its other end to a container access device 40a. The container access device 40a is associated with a container 20a having an amount of fluid (e.g., saline) that may be used to prime the flow circuit 12 and/or may be delivered to the blood source via the blood source access device 14a.
Additional tubing may be connected from one port of a cassette to another port of the same cassette, so as to form tubing loops 50 which interact with a fluid flow element or pump to flow fluid through the flow circuit 12.
As indicated, the fluid circuit 12 has a predetermined number of circuitries, and the fluid processing system 10 controls fluid flow according to pre-programmed settings ascribed to the specific blood processing procedure to be conducted. Therefore, it is desirable that the correct access tool 40a-40d connect to the correct solution container 20a-20d. A failsafe feature is thus included in this embodiment that prevents solution processing from proceeding any further if an incorrect solution container is connected at a particular processing step.
The failsafe feature of the fluid processing system 10 is based on recognition by the system 10 of each medical solution that it processes. Medical solution bags 20, regardless of specific manufacturer, generally have components listed in or referred to in their labeling. Referring to
Referring to
Each time a solution container 20 is to be connected to the system 10, the human operator may be prompted to follow one or more stages of these authentication procedures. These features may be implemented across different manufacturers and product lines. In the event that the solution is not approved by the system 10, the user may be prompted in step 5b using a number of different methods, including for example, an alarm, a prompt for the user to re-enter, a lock on the machine to prevent further use, a prompt for the user to enter the identifier, perhaps with an approval code from a manager, a termination of the procedure, a suspension of the procedure, a suspension of activity until the user corrects the error, etc. In the event that the solution is approved by the system in step 5a, the system 10 may, for example, provide a positive alert to the user, move to the next step of the procedure, increment a record of the number of times this container has been used on the system, etc.
According to an exemplary embodiment, the methodology shown in
The processing circuit of system 10 may comprise one or more analog and/or digital electronic components, such as a microprocessor, microcontroller, application-specific integrated circuit, programmable logic, etc., configured to carry out one or more of the steps described herein. The processing circuit may be programmed with an algorithm stored in a memory device configured to cause the processing circuit to carry out the steps. System 10 may further comprise a network interface circuit configured to communicate over a network (e.g., a wired or wireless network, an Ethernet, a local area network, a wide area network, a personal area network, an IEEE 802.11x network, etc.). The network interface circuit may comprise analog and/or digital components configured for communication.
The embodiments disclosed herein are for the purpose of providing a description of the present subject matter, and it is understood that the subject matter may be embodied in various other forms and combinations not shown in detail. Therefore, specific embodiments and features disclosed herein are not to be interpreted as limiting the subject matter as defined in the accompanying claims.
Number | Name | Date | Kind |
---|---|---|---|
5286959 | Demachi | Feb 1994 | A |
7753085 | Tribble | Jul 2010 | B2 |
7927313 | Stewart et al. | Apr 2011 | B2 |
8032397 | Lawless | Oct 2011 | B2 |
8291337 | Gannin | Oct 2012 | B2 |
8676600 | Case | Mar 2014 | B2 |
8685258 | Nguyen | Apr 2014 | B2 |
9671349 | Schoonover | Jun 2017 | B2 |
20020173875 | Wallace | Nov 2002 | A1 |
20030074223 | Hickle | Apr 2003 | A1 |
20030154108 | Fletcher-Haynes | Aug 2003 | A1 |
20040172169 | Wright, IV | Sep 2004 | A1 |
20050210834 | Kamineni | Sep 2005 | A1 |
20060026205 | Butterfield | Feb 2006 | A1 |
20060047538 | Condurso | Mar 2006 | A1 |
20090217202 | Foley | Aug 2009 | A1 |
20100282834 | Devergne | Nov 2010 | A1 |
20120038651 | Case | Feb 2012 | A1 |
20120041778 | Kraft | Feb 2012 | A1 |
20120315231 | Lin | Dec 2012 | A1 |
20130138452 | Cork | May 2013 | A1 |
20130334139 | Blickhan | Dec 2013 | A1 |
20140045671 | Min et al. | Feb 2014 | A1 |
20140350450 | Case | Nov 2014 | A1 |
20150355789 | O'Mahony | Dec 2015 | A1 |
20150355790 | O'Mahony | Dec 2015 | A1 |
Number | Date | Country | |
---|---|---|---|
20160051746 A1 | Feb 2016 | US |
Number | Date | Country | |
---|---|---|---|
62040660 | Aug 2014 | US |